We make people (and technology) better. Opinions are my own.

New York, USA
Joined June 2014
With some new followers on board, I wanted to take the time to re-introduce myself to the #LongCovid community (and everyone else). I’m David Putrino: Director of Rehab Innovation at @MountSinaiNYC, Associate Prof at @MountSinaiRehab for @IcahnMountSinai 1/
77
129
18
1,123
🎉 Today is the pub day for THE STORY OF THE BODY: POEMS OF ILLNESS & RECOVERY, and I couldn’t be more thrilled that this book is in the world. This is the book I wished I’d had when I was very sick. It's an oddly comforting and uplifting read, I find! 💙
8
23
3
131
6,708
Putrino Lab retweeted
Our study on virus-specific T cell activation in Long COVID (LC) is up on bioRxiv! We identify a subset of people with LC with persistently elevated activation of CD8 T cells targeting spike and/or EBV lytic antigens, consistent with viral persistence. biorxiv.org/content/10.64898…
18
149
12
411
19,443
Putrino Lab retweeted
Breaking: PolyBio-Supported Preprint Finds Persistently Activated Virus-Specific T cells in a Subset of People with Long COVID 👉🏻Virus-specific immune cells show signs of ongoing stimulation and impaired function in a subset of people with Long COVID, offering a potential way to guide targeted clinical trials 1/
9
93
12
288
12,791
Putrino Lab retweeted
Breaking: Invivyd and PolyBio network members within the SPEAR Study Group announce initiation of the “FLINTLOCK” Phase II study of VYD2311; a monoclonal antibody for the potential treatment of Long COVID and Post-Vaccination Syndrome 1/
6
29
2
103
5,519
Beyond excited to get this VERY OVERDUE study off the ground for #LongCOVID and #COVID vaccine injury with @Invivyd. Thank you so much to the team at Invyvid for making this happen. Cannot wait 🙏🏻
Invivyd and the SPEAR Study Group Announce Initiation of “FLINTLOCK” Phase 2 Study of VYD2311, a Monoclonal Antibody for the Potential Treatment of Long COVID or Post-Vaccination Syndrome investors.invivyd.com/news-r…
13
37
1
207
8,052
I'm 46 & I've been streaming for 9 years. This weekend our community finally broke 2000 sub points for the first time. Ever. In nine years. It was so emotional; tears fell. Most months we average 1000-ish. I constantly feel like a failure amongst my streamer friends. It's hard to shake the feeling that I've let my Spawners down by not being a huge channel after nearly a decade. Yet, today our tiny-yet-mighty group sits among the top 1000 on Twitch thanks to the people who never stop believing in me... even on days I don't believe in myself. I send this message to any surviving dreamers taking refuge among the stars: Never stop trying. Never give up chasing. Life is short, but life is long. In the end, you're only competing with yourself. It's never too late to achieve a dream, big or small. Keep going.
15
34
584
8,970
Putrino Lab retweeted
We’re excited to be joining the #infectiousdisease community in Washington D.C. for @IDWeekmtg! Our team will be sharing new insights on our monoclonal antibody candidate for the potential treatment and prevention of #measles. If you’re planning to attend, visit us at booth #1743. To learn more and register, visit: idweek2026.eventscribe.net/ #IDWeek2026 #IDWeek #immunization
1
4
36
1,324
Putrino Lab retweeted
Dr. Amy Proal sat down with PolyBio’s Lab Visits podcast for a conversation on the validation and FDA approvals processes for novel, candidate diagnostic markers. Said Proal, “There’s value in the wellness [diagnostics] path, but a lot of companies will also choose to go down a different path, like the LDT path with the FDA. In that case… if the test can be formally approved by the FDA… it’s much more likely to be covered by insurance.” “Everyone in the diagnostics space will tell you that groups need to think about that very early on. A lot of the key [focus] of why we’re building an incubator program at PolyBio, and making sure that people have the training and mentors… is to make these decisions optimally.”
3
18
73
3,032
Putrino Lab retweeted
In our journey to learn more about brain rehab and recovery for Lucy, we visited Burke Rehabilitation in White Plains, NY where a friend of the family recently achieved a remarkable recovery from a devastating brain hemorrhage. We toured the Burke campus and met the team and were impressed. We noted, however, that Burke is under resourced. In short, we are not doing enough for brain-injured patients at Burke and other rehabilitation centers around the country because of a lack of resources. To help advance Burke, Neri and I have a committed to a $20 million challenge grant. We will match up to $20 million of new funds raised by Burke with up to a $20 million endowment that we will manage for the center. If you would like to contribute to this initiative, please follow this link: burke.org/giving/unlock-poss… A video of Burke Rehab can be found here: youtube.com/watch?v=xPxcKXxI…
105
152
7
1,722
106,875
This month's #AMA with @PutrinoLab will be this Friday, 10/16, at 2pm Eastern/11am Pacific! Join us on Instagram and Youtube @coresinai.
1
5
15
1,114
Putrino Lab retweeted
The Ackman Oxman Institute is seeking to hire a CFO to oversee our financial and other operations. We are looking for an executive who shares our passion and commitment to build the world's preeminent patient-centric scientific, translational, clinical, and entrepreneurial brain institute headquartered in New York City. Our ambition is to save, rehabilitate, and completely restore the lives of those with brain-related diseases and brain injury as well as improve the performance and extend the longevity of healthy humans. We will seek to achieve this objective by dramatically reducing the time from idea to innovation to patient treatment. Interested candidates can submit their CV and a brief cover note to [email protected]. We will protect the confidentiality of all applicants. Candidate Profile Must-Have CFO or similar finance and operating experience in an organization combining mission and operating complexity in for-profit and/or non-profit organizations. Strong budgeting, financial planning, modeling, and strategy skills. Comfort operating with a small, efficient team that leans on AI for productivity. Experience in business formation and investment. Expertise in AI, cost control, and real estate. Comfort in building a team from scratch and designing the necessary systems to manage long-term growth. Strongly Preferred Experience with hybrid nonprofit/for-profit structures (institute-affiliated venture funds, subsidiaries, UBIT). Experience with philanthropic mega-gifts and their governance requirements. Healthcare revenue-cycle and reimbursement literacy. Experience with related-party transactions and conflict-of-interest processes.
At midnight on February 6th, earlier this year, the doorbell to our apartment rang. The doorbell was followed by a pounding on the door. I answered the door and a security person in our building handed me his phone. It was my oldest daughter Eloise. She had found my 26-year-old daughter unconscious on the floor of her apartment and had called 911. The EMT team was already there, but they did not know what was wrong with Lucy or to which hospital they would take her. I threw on some clothes and jumped in an Uber heading east toward Brooklyn. (Lucy lived alone in Williamsburg.) On the way, I learned that they were taking her to Elmhurst, a City trauma hospital in Queens. I arrived about five minutes after the ambulance to join Eloise, Lucy’s mom, and a friend, and waited to learn what was wrong. After about 15 minutes, I asked a nurse where she was. I looked over his shoulder to his computer. Next to her name, it said “non-responsive.” I walked into the emergency room and wandered around looking for her until I found her unconscious on a gurney surrounded by several doctors and nurses. By about 2:30am with the results from a CAT scan, Lucy’s doctors had determined that she had a massive brain hemorrhage and would need an emergency hemicraniectomy to release the pressure on her brain and remove the blood from the hemorrhage. I called our wonderful friend and family doctor Eddie Fisher and explained what was going on. He woke up Josh Bederson, Chairman of Neurosurgery at Mount Sinai, to find out more about Zach Hickman, the neurosurgeon on call that night. Dr. Bederson said Hickman was an excellent surgeon, which was comforting as we had no choice. The surgery to save Lucy’s life began around 3:15am and finished around 5:30am. It was successful. The following day, I joined Lucy in an ambulance while she was being transferred to Mount Sinai on Madison Avenue. Later that day, we determined from Lucy’s Oura ring that her hemorrhage had occurred around 9am, which meant that more than 19 hours had passed from the time of the hemorrhage to the completion of the surgery to release the pressure on her brain (I only wish @ouraring had an alert for this kind of a medical event. Imagine it could call a family member if the wearer doesn’t cancel the alert). I later learned that the standard of care is not to do surgery to save a patient with a large brain bleed if more than five hours have passed since the hemorrhage. Even when the surgery is done, I was told that the likely outcome for the patient is a few months in a nursing home and death from pneumonia. When I met Lucy’s doctors, I did my best to inspire them: “Let’s see what can be accomplished if we give her the best care possible and we invest unlimited resources to restore her to life.” And I promised that whatever we learned we would make available to everyone. Dr. Chris Kellner, her neurosurgeon, and Dr. David Putrino, Director of Rehabilitation Innovation for the Mount Sinai Health System have led Lucy’s care team since that day. Words cannot describe the remarkable and compassionate care that she has received beginning with the EMT team and then from nurses, doctors, therapists, and the army of people who have worked to save her and return her to life. To this day, we have a daily Zoom where we discuss her progress and make adjustments to her care. While her care and oversight have been incredible, the learnings for the Mount Sinai team have also been elucidating and will assist in the care of many others. Lucy began in a bad place. She was in a coma for several weeks and then awoke not being able to breathe on her own, unable to walk, see or speak. Over the last six months, she has recovered her cognition – she understands everything including her circumstance – is able to walk a hundred or more steps at a time with assistance, is making progress with sounds, vowels and consonants and the beginnings of speech, but she remains unable to see. Each day, she makes a little progress, and daily progress compounds. Every day I tell her that she just needs to make a little progress and it won’t be long before she is back. We remain optimistic that Lucy will return to normal function. It will likely take years, but I believe it is only a matter of time, hard work, and technological progress, along with some, and perhaps a lot, of divine intervention. Many people have been praying for Lucy and we are incredibly grateful for the prayers and remarkable support she has received. Lucy’s friends have been with her every day since the beginning, and their presence and friendship have saved her life and helped to rebuild and maintain her spirit. And on a very positive note, Lucy’s challenge has brought together our entire modern family who have all been incredibly devoted to her care and recovery. Lucy's vision and other faculties may require some form of brain computer interface, work that is underway at Neuralink, Precision Neuroscience, Science, Synchron, Nudge, and other companies in the space. If you are going to have a devastating brain injury, now is the best time in history for that to happen. We are living in a world when you can be confident that the blind will soon see again. We are going to do everything we can to help make that happen, including by assisting existing companies in the space. With respect to our promise to make Lucy’s care available to others, we have made good progress. In May, a real estate colleague made me aware of a 93% vacant, brand new, 400,000 square foot Class A+ purpose-built biotech facility on West End Avenue between 65th and 66th Streets that missed the market and was available for sale. The Pershing Square Foundation acquired the building 60 days later. We also put under contract an adjoining 130,000 square foot building at 320 West 66th Street that is currently being used by Saturday Night Live for studio space. The building has 35-foot ceilings with massive column-free spaces that can be converted into superb rehabilitation facilities. We will close on the SNL building in December. We are also acquiring an adjoining vacant lot with additional air rights. With just the existing zoning rights, we can add a 150,000 square feet for a total of 680,000 square feet, a lab footprint larger than Rockefeller University, and that’s without including the potential for an upzoning that would allow for substantially more buildable area on the site’s 3.4 acres with spectacular views of the Hudson. Our goal is to build the world’s greatest brain research, rehabilitation, recovery, human optimization, and longevity institute. We have named it The Ackman Oxman Institute or the AOI for lack of a better name, but also to reinforce the point that Neri and I and our family are all-in on the mission. The AOI will be patient-centric. It will not be an academic research institute that produces lots of papers, a Nobel Prize winner or two, but little if any results for patients. We will be laser-focused on cures, treatments, devices, rehabilitation and exercise equipment, and targeted and basic research with a goal of massively accelerating the time from idea to innovation to production to helping a patient. While the AOI will be a non-profit, it will have highly commercial instincts. The AOI will have its own venture funding and will work to develop innovations to create companies that we will seed, assist, and spinout to ensure technologies, treatments, techniques, and drugs get to patients as promptly as possible. On one 3.4 acre campus in what is still the greatest city in the world, we will do neurosurgery, neuroscience, rehabilitation, nutrition, BCI and device development, human trials, hyperbaric oxygen treatments, and life extension programs, and we will mandate and incentivize collaboration among the teams with no silos, politics, bureaucracy, or any other constraint that is inconsistent with the mission. Mount Sinai will be an important partner and deservedly so, but it won’t be our only hospital or medical school partner as we don’t believe any institution has a monopoly on the best ideas or the best talent. We don’t believe in exclusive relationships because that is not in the best interest of patients. Five years ago, we considered launching a brain institute inspired by Neri’s mom who sadly died from Alzheimer’s. We couldn’t make the math work as the real estate was too expensive and we believed it would be too difficult to recruit the best talent from universities to our effort. Since then, the real estate became available at a 70% discount, universities became a much less attractive place to work due to politics outweighing meritocracy, protests that disrupt learning, the curse of antisemitism, and a decline in funding. Fortunately, during the same time, I made sufficient personal economic progress to make the AOI possible. The advance of AI in the last few years will also enable us to greatly accelerate our mission. AI still has a lot to learn about human intelligence and the brain, and the AOI should be at the forefront of the interplay between the brain and AI. Today, I am making a public filing disclosing a gift from Neri and me of ~$400 million or 10,000,000 shares of Pershing Square Inc. (PS) to the AOI. It is very early days for Pershing Square so these shares are intended to anchor the long-term work of the AOI as the shares compound over time while generating what we expect will be a growing stream of quarterly dividends to fund the Institute. We will also be announcing an additional gift of similar and potentially greater size which won’t be in the form of Pershing Square stock to provide the AOI with the short- and intermediate-term runway necessary to enable it to achieve its goal of becoming a self-sustaining institute, which reinvests all of its revenues, royalties, and the economic rewards of company formation to advance the fields of brain health and human longevity. Neri and I have chosen to anchor the funding of the AOI to maintain vision alignment and limit the need for the organization to focus on fundraising. We expect the AOI to be the best-resourced brain, rehab, recovery, and longevity institute in the world. We are grateful to have been able to form a board which includes Dean Kamen (our generation’s Thomas Edison), George Yancopoulus (CEO of Regeneron), James Rothman (Nobel Laureate), Bernardo Sabatini (neuroscientist), Chris Kellner (neurosurgeon), Olivia Flatto (CEO Pershing Square Foundation), Neri Oxman, and myself. We have recently identified a CEO who we expect to announce by October along with other key hires, and are beginning searches for a Chief Scientific Officer, a Chief AI/Technology Officer, a Chief Operating Officer, a Chief Financial Officer, and other key leadership roles. If you find what we are building compelling and want to be part of the leadership team that creates and builds the AOI from a standing start, please send an email to: [email protected] with a short note as to why you believe you can help. Please include your best three ideas for the AOI along with a summary of your background and your most important accomplishments. We promise strict confidentiality to those expressing interest in working with us. We have learned from Lucy that the brain can recover from even catastrophic injury. There is so much more work to be done as the mind is a terrible thing to waste. For details from my Pershing Square SEC filing see: sec.gov/Archives/edgar/data/…
53
66
6
735
174,878
Facing tough news, I often try humor to cope with adversity on my Long Covid and Cancer journey. With a tough week, I went to create drawing inspiration from one of my favorite movies, Stanley Kubrick's "The Shining" #cancer #podcast podcasts.apple.com/us/podcas… Will update soon
3
4
1
24
1,188
I’m doing a 5K on October 18th to support research at the Tulane Cancer Center, here in the Deep South. I wanted to do something fun, so in addition to wearing an N95, I will wear an additional N95 on my person for every $50 donated (runsignup.com/mask). $50 = 1 N95 $500 = 10 N95s $5,000 = 100 N95s $50,000 = 1,000 N95s Any partial donation would help. $10 would add an additional mask for 1K of the race. A penny would add 1 meter with an additional mask. I’ll sum partial donations and round up in the end. Even a penny🪙 or reshare🔁 would help. FAQs World Record 🔹There does not presently appear to be a Guinness World Record for most N95s on an individual in a 5K. 🔹This year, I will go for an informal record. Guinness has not yet responded to my request to go for an official record, but there is always next year. Good Health, Safety, and Environmental Modeling 🔹I will mask properly. Extra masks will not be worn on top of my mask. 🔹All masks will be individually-wrapped N95s. I will eventually wear them or donate them, if someone wants them. Caveats 🔹It’s a fun run. All donations are final, even if weather or an injury strikes. Inclusivity 🔹There are many ways to support health and health justice. Please also contribute to your local mask bloc or engage in advocacy in other ways too. There are many great causes. 🔹Many people with chronic and serious illnesses are housebound or cannot run or could run but would then crash for days or weeks after. This is no endorsement of the primacy of exercise-based activities. How Your Donation Helps 🔹Your donation supports the fight against cancer and normalizes masking. 🔹Funds support the Tulane Cancer Center. Last year’s funds went toward a project to reduce the chances of bone metastases in the context of breast cancer. 🔹I avoid financial conflicts of interest like the plague, so I will not accept any payments or apply for any funds. Please help spread the word!
29
171
12
556
58,605
The Significant Impact of high quality PT on stroke recovery. We discuss this and much more with Dr. David Putrino on the latest podcast. Click here to check out the entire episode: principlesofperformance.blub… or on YouTube: youtu.be/BIiYZwIRuLA @PutrinoLab
2
5
499
The latest podcast is now live and this one is fascinating! We are joined by Dr. David Putrino of Mount Sinai Hospital. Click here to check out the entire episode: principlesofperformance.blub… or on YouTube: youtu.be/BIiYZwIRuLA
1
1
4
471
Today @KarlDeisseroth of @StanfordMed @Stanford won the @NobelPrize for his co-discovery & development of Optogenetics. Here he explains what that is, and how it is unlocking the secrets of brain function & helping to cure diseases. (And he explains that in ~1min).
77
879
78
4,387
301,580
Congrats to all the winners, but hugely happy for Karl: changed the game in neuroscience and has never stopped innovating since. Big congrats too @michelle_monje 🎉
BREAKING NEWS The 2026 #NobelPrize in Physiology or Medicine has been awarded to Karl Deisseroth, Peter Hegemann and Georg Nagel “for their discoveries concerning light-gated ion channels and optogenetics.”
1
4
50
2,453
Happy Sunday! Just a friendly reminder that there is no such thing as "false hope". "We must accept finite disappointment, but never lose infinite hope." - Martin Luther King Jr Have a great day!
11
10
5
138
14,599
Putrino Lab retweeted
Dr. Amy Proal, PolyBio Scientific Director, recently joined “Lab Visits” to discuss the process of commercializing and gaining regulatory approval for Long COVID diagnostics. She explained how PolyBio is building a diagnostic incubator program to connect promising early-stage diagnostic teams with guidance and expertise in regulatory strategy, FDA approval, reimbursement, and other key areas of development. Said Proal, “Our focus now really is taking what we’re learning from the academic research, and making it work in the real world. And that’s because our goal, ultimately, as a foundation, is to get treatments to patients as rapidly as possible.”
16
31
5
160
9,935